| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/20/2001 | EP1108035A2 Treatment of cervical cancer |
| 06/20/2001 | EP1108026A1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 06/20/2001 | EP1108025A2 Phelix: a testis-specific protein expressed in cancer |
| 06/20/2001 | EP1108017A2 G-motif oligonucleotides and uses thereof |
| 06/20/2001 | EP1108016A2 Mapkap kinase 2-inhibitors and the use thereof in anti-inflammatory therapy |
| 06/20/2001 | EP1108013A2 Genes associated with neurotransmitter processing |
| 06/20/2001 | EP1108008A1 Novel ubiquitin ligases as therapeutic targets |
| 06/20/2001 | EP1107989A2 Expression and export of angiostatin and endostatin as immunofusins |
| 06/20/2001 | EP1107977A1 Ratc |
| 06/20/2001 | EP1107974A1 Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof |
| 06/20/2001 | EP1107973A1 Novel compounds |
| 06/20/2001 | EP1107971A1 Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them |
| 06/20/2001 | EP1107970A2 Collections of compounds |
| 06/20/2001 | EP1107969A2 Collections of compounds |
| 06/20/2001 | EP1107968A2 Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one |
| 06/20/2001 | EP1107967A2 Triazolopyridazine derivatives for treating anxiety and enhancing cognition |
| 06/20/2001 | EP1107966A2 Oxo-pyridoimidazole-carboxamides: gaba brain receptor ligands |
| 06/20/2001 | EP1107965A1 Pyridyl ethers and thioethers as ligands for nicotinic acetylcholine receptor and its therapeutic application |
| 06/20/2001 | EP1107964A1 Isoquinoline derivatives with angiogenesis inhibiting activity |
| 06/20/2001 | EP1107963A1 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 06/20/2001 | EP1107962A1 Quinolin-2-one derivatives useful as anticancer agents |
| 06/20/2001 | EP1107961A1 Inhibition and treatment of hepatitis b virus and flavivirus by helioxanthin and its analogs |
| 06/20/2001 | EP1107960A1 Pyrazine compounds |
| 06/20/2001 | EP1107959A2 Quinazoline derivatives as medicaments |
| 06/20/2001 | EP1107958A1 Pyrimidine compounds |
| 06/20/2001 | EP1107957A1 Pyrimidine compounds |
| 06/20/2001 | EP1107954A1 2-OXO-$i(2H)-QUINOLINE DERIVATIVES |
| 06/20/2001 | EP1107953A1 Hydroxamic acid derivatives as proteinase inhibitors |
| 06/20/2001 | EP1107944A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 06/20/2001 | EP1107940A1 Vitamin d3 mimics |
| 06/20/2001 | EP1107813A1 Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers or covering structures |
| 06/20/2001 | EP1107812A1 Gelatinous body protection article having a therapeutic additive |
| 06/20/2001 | EP1107807A1 Method of enhancing catheter patency using a citrate salt catheter lock solution |
| 06/20/2001 | EP1107797A2 Hypoxia regulated genes |
| 06/20/2001 | EP1107795A2 Methods and compositions for the prevention or treatment of cancer |
| 06/20/2001 | EP1107790A1 Targeting of molecules to large vessel endothelium using epcr |
| 06/20/2001 | EP1107789A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 06/20/2001 | EP1107788A1 Scrp-5: secreted cysteine rich protein-5 |
| 06/20/2001 | EP1107784A2 Activation and protection of t-cells (cd4?+ and cd8?+ ) using an h 2? receptor agonist and other t-cell activating agents |
| 06/20/2001 | EP1107775A1 Composition containing pyrrolizidine-alkaloid-free petasites |
| 06/20/2001 | EP1107772A2 Probiotic, lactic acid-producing bacteria and uses thereof |
| 06/20/2001 | EP1107767A2 Use of selenium for treating patients suffering from systemic inflammatory response syndrome (sirs), and composition for implementing said treatment |
| 06/20/2001 | EP1107765A2 3-deazaadenosine prevents atherosclerosis and graft vasculopathy |
| 06/20/2001 | EP1107763A1 Controlled release tablet comprising a hypoglycemic drug and an antihyperglycemic drug |
| 06/20/2001 | EP1107762A1 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure sexual dysfunction in women |
| 06/20/2001 | EP1107761A2 4-quinolinemethanol derivatives as purine receptor antagonists (ii) |
| 06/20/2001 | EP1107760A2 4-quinolinemethanol derivatives as purine receptor antagonists (i) |
| 06/20/2001 | EP1107759A1 Pyridinones for the treatment of sexual dysfunction |
| 06/20/2001 | EP1107758A2 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase |
| 06/20/2001 | EP1107757A2 Carbamate and urea compositions and neurotrophic uses |
| 06/20/2001 | EP1107756A1 Novel isoxazolinone antibacterial agents |
| 06/20/2001 | EP1107755A1 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 06/20/2001 | EP1107754A1 Ureas and carbamates of n-heterocyclic carboxylic acids and isosteres for vision and memory disorders |
| 06/20/2001 | EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 06/20/2001 | EP1107752A1 Pyrrolidine derivatives for vision and memory disorders |
| 06/20/2001 | EP1107751A2 Medicament containing platinum complex compounds and the use thereof |
| 06/20/2001 | EP1107750A2 Pharmaceutical composition with antitumor activity on the basis of carboplatin |
| 06/20/2001 | EP1107749A2 The use of fumaric acid derivatives in transplant medicine |
| 06/20/2001 | EP1107748A2 Methods and compositions employing optically pure s(+) vigabatrin |
| 06/20/2001 | EP1107747A1 Therapies for treating pulmonary diseases |
| 06/20/2001 | EP1107746A2 Methods of using and compositions comprising dopamine reuptake inhibitors |
| 06/20/2001 | EP1107745A1 Use of 5ht-6 antagonists |
| 06/20/2001 | EP1107744A2 Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of nk-1 receptor antagonists for the treatment of chronic fatigue syndrome |
| 06/20/2001 | EP1107741A1 Orally administered controlled drug delivery system providing temporal and spatial control |
| 06/20/2001 | EP1107740A1 Timed release tablet comprising naproxen and pseudoephedrine |
| 06/20/2001 | EP1107738A1 Novel pharmaceutical salt form |
| 06/20/2001 | EP1107737A1 Microparticles |
| 06/20/2001 | EP1107735A1 Omeprazole formulation |
| 06/20/2001 | EP1107732A1 Oral liquid mucoadhesive compositions |
| 06/20/2001 | EP1107731A1 Synthetic tear fluid |
| 06/20/2001 | EP1107730A2 Medicated chewing gum delivery system for nicotine |
| 06/20/2001 | EP1107723A2 A carotenoid composition containing phytoene and phytofluene |
| 06/20/2001 | EP1107722A2 A method for the treatment of staphylococcal disease |
| 06/20/2001 | EP1107702A1 Ultrasonic enhancement of drug injection |
| 06/20/2001 | EP0984961B1 Novel pyridine derivatives and pharmaceutical compositions containing them |
| 06/20/2001 | EP0934301B1 Aminothiophene carboxylic acid amides and the use thereof as phosphodiesterase inhibitors |
| 06/20/2001 | EP0929515B1 Novel phenoxyethylamine derivatives, method of preparation, application as medicine and pharmaceutical compositions containing same |
| 06/20/2001 | EP0920438B1 N6 heterocyclic substituted adenosine derivatives |
| 06/20/2001 | EP0889902B1 Antibiotic peptides from bovine milk |
| 06/20/2001 | EP0889875B1 Cyclopropyl alkanoic acid derivatives |
| 06/20/2001 | EP0820438B1 O-carbamoyl-phenylalaninol having substituent at benzene ring, its pharmaceutically useful salts and method for preparing the same |
| 06/20/2001 | EP0817621B1 Pharmaceutical composition for transdermic delivery |
| 06/20/2001 | EP0808303B1 5-(4-subst.-piperidinyl-1)-3-aryl-pentanoic acid derivatives as tachykinin receptor antagonist |
| 06/20/2001 | EP0796260B1 Rapamycin 42-oximes and hydroxylamines |
| 06/20/2001 | EP0768308B1 derivatives of pyroglutaminic acid, preparation process and applications |
| 06/20/2001 | EP0767658A4 Anti-acne cosmetic compositions |
| 06/20/2001 | EP0757682B1 Benzofuran derivatives useful as inhibitors of bone resorption |
| 06/20/2001 | EP0741732B1 Process for the preparation of a salt of clavulanic acid |
| 06/20/2001 | EP0733043B1 Tricyclic derivatives and their use in pharmaceuticals |
| 06/20/2001 | EP0714394B1 Antipsychotic method with thiadiazole and oxadiazole derivatives |
| 06/20/2001 | EP0686037B1 Hormone replacement therapy |
| 06/20/2001 | EP0662157B1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 06/20/2001 | EP0579733B1 Thiazolidinedione derivatives, production and use thereof |
| 06/20/2001 | CN1300367A Methods and compositions for diagnosis of rheumatoid arthritis |
| 06/20/2001 | CN1300303A Enzyme inhibitors |
| 06/20/2001 | CN1300291A Modulators of protein tyrosine phosphatases |
| 06/20/2001 | CN1300290A Novel cephalosporin compounds, processes for preparation thereof and antimicrobial compositions containing the same |
| 06/20/2001 | CN1300289A Novel cephalotaxane derivatives and process for their preparation |
| 06/20/2001 | CN1300288A Water soluble azoles as broad-spectrum antifungals |
| 06/20/2001 | CN1300287A Water soluble azoles as broad-spectrum antifungals |